Jia Jie Biomedical Co Ltd Capital Reinvestment Ratio
Jia Jie Biomedical Co Ltd capital reinvestment ratio. Jia Jie Biomedical Co Ltd (4109) has a Capital Reinvestment Ratio of 0.45x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$12.96 Million) in capital expenditures (NT$5.84 Million). See cash generation quality of Jia Jie Biomedical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jia Jie Biomedical Co Ltd (2015–2025)
Capital reinvestment ratio of Jia Jie Biomedical Co Ltd from 2015 to 2025. This chart tracks Jia Jie Biomedical Co Ltd's Capital Reinvestment Ratio across 6 annual periods. See 4109 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Jia Jie Biomedical Co Ltd Capital Reinvestment Ratio by Year (2015–2025)
Jia Jie Biomedical Co Ltd capital reinvestment ratio by year from 2015 to 2025. For the full cash flow conversion analysis, see how efficiently does Jia Jie Biomedical Co Ltd generate cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.01x | NT$21.34 Million | NT$85.50 Million | ▲ +805.1% |
| 2024 | 0.44x | NT$44.35 Million | NT$19.63 Million | ▲ +27.4% |
| 2021 | 0.35x | NT$4.37 Million | NT$1.52 Million | ▲ +476.4% |
| 2020 | 0.06x | NT$27.10 Million | NT$1.63 Million | ▼ -51.2% |
| 2019 | 0.12x | NT$24.71 Million | NT$3.05 Million | ▼ -96.3% |
| 2015 | 3.33x | NT$82.22 Million | NT$273.85 Million | — |